Design of highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

被引:0
|
作者
Schnute, Mark E. [1 ]
Ruminski, Peter G. [1 ]
Massa, Mark A. [2 ]
Strohbach, Joseph W. [2 ]
Hanau, Cathleen E. [1 ]
Schmidt, Michelle A. [2 ]
Shieh, Huey S. [1 ]
Caspers, Nicole [2 ]
Collins, Brandon [2 ]
Carroll, Jeffery N. [1 ]
Fletcher, Theresa R. [1 ]
Hamper, Bruce C. [1 ]
Scholten, Jeffrey A. [1 ]
Rogers, Michael D. [1 ]
Grapperhaus, Margaret L. [2 ]
Hitchcock, Jeff [2 ]
Collins, Joe [2 ]
McDonald, Joseph [1 ]
O'Brien, Patrick [2 ]
Munie, Grace E. [2 ]
Messing, Dean M. [2 ]
Portolan, Silvia [2 ]
Settle, Steven L. [2 ]
Nemirovskiy, Olga [2 ]
Vickery, Lillian [2 ]
Sunyer, Teresa [2 ]
机构
[1] Pfizer Global Res & Dev, Dept Chem, St Louis, MO 63017 USA
[2] Pfizer Inc, Global Res & Dev, St Louis, MO 63017 USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 237卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
145-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Discovery of highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Scholten, Jeffrey A.
    O'Brian, Patrick M.
    Nahra, Joe
    Morris, Mark
    Roark, William H.
    Hanau, Cathleen E.
    Ruminski, Peter G.
    Fletcher, Theresa R.
    Hamper, Bruce C.
    Shieh, Huey S.
    Collins, Brandon
    McDonald, Joseph
    Rogers, Michael D.
    Carroll, Jeffery N.
    Johnson, Adam
    Munie, Grace E.
    Man, Chiu-Fai
    Settle, Steven L.
    Nemirovskiy, Olga
    Vickery, Lillian
    Agawal, Arun
    Sunyer, Teresa
    Schnute, Mark E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [2] Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Hu, YH
    Xiang, JS
    DiGrandi, MJ
    Du, XM
    Ipek, M
    Laakso, LM
    Li, JC
    Li, W
    Rush, TS
    Schmid, J
    Skotnicki, JS
    Tam, S
    Thomason, JR
    Wang, Q
    Levin, JI
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (24) : 6629 - 6644
  • [3] Potent, selective and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Hu, Yonghan
    DiGrandi, Martin J.
    Du, Xuemei
    Ipek, Manus
    Laakso, Leif M.
    Li, Jianchang
    Li, Wei
    Rush, Thomas S.
    Schmid, Jean
    Skotnicki, Jerauld S.
    Tam, Steve
    Thomason, Jennifer R.
    Xiang, Jason S.
    Wang, Qin
    Levin, Jeremy I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2665 - U2666
  • [4] Bicyclic heterocycles as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Li, Jie Jack
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [5] Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents
    Xie, Xin-Wen
    Wan, Ren-Zhong
    Liu, Zhao-Peng
    CHEMMEDCHEM, 2017, 12 (15) : 1157 - 1168
  • [6] Synthesis of potent and selective nonzinc binding matrix metalloproteinase-13 inhibitors
    Carroll, Jeffery N.
    Fletcher, Theresa R.
    Hamper, Bruce C.
    Scholten, Jeffrey A.
    Hanau, Cathleen E.
    Ruminski, Peter G.
    Rogers, Michael D.
    Grapperhaus, Margaret L.
    Massa, Mark A.
    Schmidt, Michelle A.
    Shieh, Huey S.
    Caspers, Nicole
    McDonald, Joseph
    Munie, Grace E.
    Messing, Dean M.
    Portolan, Silvia
    Sunyer, Teresa
    Schnute, Mark E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [7] Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Schnute, Mark E.
    O'Brien, Patrick M.
    Nahra, Joe
    Morris, Mark
    Roark, W. Howard
    Hanau, Cathleen E.
    Ruminski, Peter G.
    Scholten, Jeffrey A.
    Fletcher, Theresa R.
    Hamper, Bruce C.
    Carroll, Jeffery N.
    Patt, William C.
    Shieh, Huey S.
    Collins, Brandon
    Pavlovsky, Alexander G.
    Palmquist, Katherine E.
    Aston, Karl W.
    Hitchcock, Jeffrey
    Rogers, Michael D.
    McDonald, Joseph
    Johnson, Adam R.
    Munie, Grace E.
    Wittwer, Arthur J.
    Man, Chiu-Fai
    Settle, Steven L.
    Nemirovskiy, Olga
    Vickery, Lillian E.
    Agawal, Arun
    Dyer, Richard D.
    Sunyer, Teresa
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 576 - 580
  • [8] Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis
    Xin, Xing
    Tan, Qizhao
    Li, Fang
    Chen, Zhongqiang
    Zhang, Ke
    Li, Feng
    Yang, Bin
    Xing, Zhili
    Zhou, Fang
    Tian, Yun
    Lv, Yang
    Zhu, Tengjiao
    FRONTIERS IN SURGERY, 2021, 8
  • [9] Matrix metalloproteinase-13 inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (10) : 478 - 479
  • [10] REGULATION OF MATRIX METALLOPROTEINASE-13 BY MIRNA-320 IN CHONDROGENESIS AND OSTEOARTHRITIS
    Zhang, Z.
    Meng, F.
    Huang, G.
    Zhang, Z.
    Mang, Y.
    Sheng, P.
    Liao, W.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S381 - S381